Established in 1989, Stason Industrial Corporation entered the US generics market with the formation of Stason Pharmaceuticals, Inc. in 1994. While venturing into NDA development, we continue to develop these products through our global network of affiliates, partners and distributors.
In 2008, we launched our Brand Division when we obtained exclusive commercialization rights to novel proprietary compounds in the area of oncology. In 2015, we acquired an NDA. For more information Click Here
In 2025, we established consumer product manufacturing divisions under Stason to develop innovative delivery methods for the supplement industry. We are continuing to expand these divisions and are adding additional capabilities to cover a wide range of products including powders in sachets, ODTs, Chewables, and functional Chewing gum, in addition to traditional tablets and capsules.